View printer-friendly version << Back
Pediatrix Expects 2002 EPS of Between $2.30 to $2.40

    FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Oct. 31, 2001--Pediatrix Medical Group, Inc., (NYSE:PDX) today announced expanded earnings guidance for calendar year 2002, increasing estimated earnings of $2.30 to $2.40 per share, including the positive impact from the elimination of goodwill amortization.
    Pediatrix provided the guidance this morning on a conference call following the release of its 2001 third quarter results.
    Previous guidance, issued in August following the second quarter earnings report, were for Pediatrix to earn between $2.15 to $2.30 per share, including the elimination of goodwill amortization.

    Investor Conference Call

    A telephone replay of the conference call will also be available from 2:30 p.m. (EST) today through midnight (EST) November 7, 2001 by dialing (800) 475-6701, access code: 607071. A webcast replay of the conference call is also available at

    About Pediatrix

    Pediatrix was founded in 1979. Its neonatal physicians provide services at more than 185 NICUs and through Obstetrix its perinatal physicians provide services in 16 markets where Pediatrix's neonatal physicians practice. Combined, Pediatrix and its affiliated professional corporations employ more than 575 physicians in 27 states and Puerto Rico. Additional information is available on the Internet:

    Except for historical information, matters discussed in this release include forward-looking statements that involve risks and uncertainties including, but not limited to, business, financial and integration risks. In addition, Pediatrix details other risk factors in its Annual Report on Form 10-K for the year ended December 31, 2000, filed with the U.S. Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from those projected or anticipated in the forward-looking statements.
    The forward-looking statements in this press release are made as of the date hereof based on management's current beliefs and expectations, and the Company undertakes no obligation to update or revise any such statements, whether as result of new developments, new information or otherwise.


    CONTACT:  Pediatrix Medical Group, Inc., Fort Lauderdale
              Bob Kneeley, 954/384-0175, x-5300

    SOURCE:  Pediatrix Medical Group, Inc.